SV Health Investors

SV Health Investors (formerly SV Life Sciences) is a specialist healthcare private equity and venture capital firm that invests across three dedicated strategy-specific platforms: Therapeutics, which funds early- to late-stage biotechnology companies developing precision medicines, including a dedicated Dementia Discovery Fund; Healthcare Growth, which provides growth capital and liquidity to companies operating in healthcare services, digital health, and medical products; and Medtech, which targets novel medical device and remote-monitoring technologies through its Medtech Convergence Fund. The firm pursues a multi-stage investment approach, supporting companies from early venture through late-stage growth and crossover, with transaction types spanning venture financings, growth capital investments, growth equity, recapitalizations, and acquisitions. SV Health Investors generally seeks non-controlling ownership positions, though it also takes majority stakes in select healthcare growth transactions. The firm invests primarily across the United States and Europe, with its team of more than 50 investment professionals and operating partners collaborating with management teams and entrepreneurs to guide strategic direction, build operational capability, and advance clinical and commercial development across portfolio companies. Founded in 1993, the firm is headquartered in Boston, Massachusetts, United States, with an additional office in London, United Kingdom.